Expecting a 15-17% Swing on DTIL as the stock rounds off from it's previous $12.50 Breakout Consolidation. It seems as though profit-taking has completed and the stock is moving higher in the pre-market session to solidify the swing trade. We have been watching the stock for the past few days and the Buying Volume has spiked over the course of that time period. In regards to what could push this stock even higher, the company just announcing receiving positive interim results from it's PBCAR0191 Trial as Potential Lymphoma and Leukemia Treatment. The company also has completed preclinical work for another related drug candidate: PBCAR19B, and expects it to enter the clinical trial in 2021.
Thank you for following us! Were you in any of the trades that we have been providing to the community?
natelockett
⋅
@MillennialInvestmentsPros, I just found you all when I was analyzing a trade recently. FCEL today. I noticed you all have a ton of great content so I intend on following from here on out! Thank you!
MyMIWallet
⋅
@natelockett, I appreciate the compliment on our hard work providing other traders with the information and tools to improve their investments and profit gains! Stay tuned for more to come in the near future. We release at least one Free Trade Alert everyday.
Thank you for following us! Were you in any of the trades that we have been providing to the community?